Brett Fortune

机构：Albert Einstein College of Medicine, Montefiore Medical Center

发表论文 8 篇 · 总被引 8 次 · h-index 1

代表论文

• Timely Follow‐Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population‐Based Cohort of 8852 Patients (2024 · Alimentary Pharmacology & Therapeutics · 被引 8)
• OS-089 CNP-104, an investigational antigen-specific therapy, demonstrates favorable impact across multiple analyses of liver stiffness measurement in a Phase 2a randomized, placebocontrolled trial in PBC (2026 · Journal of Hepatology)
• THU-483 BAVENO VII criteria and ANTICIPATE models predict first decompensation in a multi-center U.S. cohort of patients with compensated advanced chronic liver disease (cACLD) (2026 · Journal of Hepatology)
• United States Experience With Terlipressin in Hepatorenal Syndrome: Response, Mortality, and Transplant Outcomes - Results From the HRS Harmony Consortium (2026 · Clinical Gastroenterology and Hepatology)
• SAT-282 CNP-104, an investigational antigen-specific therapy, demonstrates evidence of improved hepatic function and prognostic risk in a phase 2a randomized, placebo-controlled trial in PBC (2026 · Journal of Hepatology)
• Mo2017 COMPARING NON-SELECTIVE BETA BLOCKERS, VARICEAL BAND LIGATION AND COMBINATION THERAPY IN PREVENTION OF DECOMPENSATION EVENTS IN PATIENTS WITH COMPENSATED CIRRHOSIS AND HIGH-RISK VARICES (2026 · Gastroenterology)